Belgian chemical and pharmaceutical company Solvay reported sharply lower net income of €25 million for the fourth quarter, down from €198 million a year earlier, with net sales down 5% at €2.42 billion.
from WSJ.com: US Business http://ift.tt/1dxQQiB
via IFTTT
from WSJ.com: US Business http://ift.tt/1dxQQiB
via IFTTT
No comments:
Post a Comment